Common diabetes drug may shield breast cancer survivors from new health threat
NCT ID NCT06763328
Summary
This study is testing whether adding the diabetes medication metformin to standard healthy lifestyle advice can better prevent or reverse insulin resistance in women who have finished chemotherapy for early-stage breast cancer. Researchers want to see if metformin helps normalize blood sugar levels in these survivors, as chemotherapy can increase diabetes risk. The trial will compare metformin plus lifestyle education against lifestyle education alone in 200 participants over 12 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC San Diego Moores Cancer Center
NOT_YET_RECRUITINGLa Jolla, California, 92093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of California-Riverside
NOT_YET_RECRUITINGRiverside, California, 92521, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.